Daxor Profit Margin 2010-2011 | DXR

Current and historical gross margin, operating margin and net profit margin for Daxor (DXR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Daxor net profit margin as of December 31, 2011 is 0%.
Daxor Annual Profit Margins
Daxor Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.044B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.436B 11.76
Quest Diagnostics (DGX) United States $16.207B 16.62
DaVita (DVA) United States $12.051B 14.97
Encompass Health (EHC) United States $9.224B 23.61
Chemed (CHE) United States $8.315B 25.42
Elanco Animal Health (ELAN) United States $6.375B 16.54
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.579B 95.35
Amedisys (AMED) United States $3.211B 23.01
Astrana Health (ASTH) United States $2.923B 39.55
Addus HomeCare (ADUS) United States $2.235B 28.93
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.481B 39.65
Pennant (PNTG) United States $0.881B 46.52
Aveanna Healthcare Holdings (AVAH) United States $0.845B 0.00
Atai Life Sciences (ATAI) Germany $0.266B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Psychemedics (PMD) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00